Student Well-Being

Firm Moves Closer To Brain-Imaging Test for ADHD

By Darcia Harris Bowman — March 28, 2001 2 min read
  • Save to favorites
  • Print

A Boston company is nearing the final phase of testing a diagnostic drug that could offer health-care providers a long-awaited medical test for attention deficit hyperactivity disorder.

Boston Life Sciences Inc. announced this month that its product Altropane was successful in identifying adults who had been clinically diagnosed with long- standing ADHD by mapping the level of certain chemicals in their brain.

ADHD is the most commonly diagnosed behavioral disorder in American children, affecting an estimated 2 million school-age youngsters, according to the National Institutes of Health. Characterized by hyperactivity, short attention spans, and impulsivity, the condition often interferes with a child’s education.

No biological test for diagnosing ADHD is currently available, a situation that some experts contend has led to the misdiagnosis and unnecessary medication of many children. Currently, psychiatrists often rely heavily on reports from parents and educators about children’s behavior in making a diagnosis.

Researchers working on the development of Altropane say their study has shown abnormally high levels of the neurotransmitter dopamine in the brains of people with ADHD, which means a medical diagnosis may not be far away.

“Because of the national controversy presently surrounding the confusion and inconsistencies in the clinical diagnosis of ADHD, and the growing concern over the abuse of stimulant medications by schoolchildren, we believe that the need for an objective, biologically based diagnosis for ADHD has never been greater, nor more urgent for society,” Marc Lanser, Boston Life Science’s chief scientific officer, said in a written statement.

Under guidelines set by the U.S. Food and Drug Administration, the company conducted the first test of its imaging product in 1999 on 10 adult volunteers, six with ADHD, and increased the number of test subjects to 40 for the second phase. The results of the first study were published in The Lancet, a London-based journal of medicine.

The third and final trial of Altropane is to begin this summer with 100 adult test subjects.

Once the testing is wrapped up, Boston Life Sciences will apply to the FDA for fast-track approval to market the product, said Maria Zapf, the company’s manager of corporate affairs.

“Hopefully, this kind of product will quell a little of the controversy over whether ADHD is an actual disorder,” Ms. Zapf said.


Coverage of research is underwritten in part by a grant from the Spencer Foundation.

Related Tags:

A version of this article appeared in the March 28, 2001 edition of Education Week as Firm Moves Closer To Brain-Imaging Test for ADHD

Events

School & District Management K-12 Essentials Forum Get a Strong Start to the New School Year
Get insights and actions from Education Week journalists and expert guests on how to start the new school year on strong footing.
Reading & Literacy Webinar A Roadmap to Multisensory Early Literacy Instruction: Accelerate Growth for All Students 
How can you develop key literacy skills with a diverse range of learners? Explore best practices and tips to meet the needs of all students. 
This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
College & Workforce Readiness Webinar
Supporting 21st Century Skills with a Whole-Child Focus
What skills do students need to succeed in the 21st century? Explore the latest strategies to best prepare students for college, career, and life.
Content provided by Panorama Education

EdWeek Top School Jobs

Teacher Jobs
Search over ten thousand teaching jobs nationwide — elementary, middle, high school and more.
View Jobs
Principal Jobs
Find hundreds of jobs for principals, assistant principals, and other school leadership roles.
View Jobs
Administrator Jobs
Over a thousand district-level jobs: superintendents, directors, more.
View Jobs
Support Staff Jobs
Search thousands of jobs, from paraprofessionals to counselors and more.
View Jobs

Read Next

Student Well-Being Should Medical Marijuana Be Allowed in Schools?
Many states are leaving it up to schools and districts to decide if students can take cannabis as medication.
7 min read
An employee at a medical marijuana dispensary in Egg Harbor Township, N.J., sorts buds into prescription bottles on March 22, 2019.
An employee at a medical marijuana dispensary in Egg Harbor Township, N.J., sorts buds into prescription bottles in 2019.
Julio Cortez/AP
Student Well-Being Opinion How Trauma-Informed Practice Made Me a Better Teacher
Students aren’t the only ones who need help managing their emotional responses. Here’s where to start.
Melody Hawkins
4 min read
Conceptual illustration of learning through trauma
DigitalVision Vectors/Getty
Student Well-Being What the Feds' Latest Move on Monkeypox Vaccines Means for Young People
Adults can get a reduced dose of vaccine, but younger people would still receive the traditional shot under an emergency use authorization.
1 min read
Image of a band aid being applied after a vaccination.
iStock/Getty
Student Well-Being The Monkeypox Outbreak: What School Leaders Need to Know
Officials have declared monkeypox a public health emergency, but school leaders shouldn't panic, experts say.
4 min read
A visitor checks in at a pop-up monkeypox vaccination site at the West Hollywood Library on Wednesday, Aug. 3, 2022, in West Hollywood, Calif. The City of West Hollywood is working with public health officials at the Los Angeles County Department of Public Health in responding to the monkeypox outbreak.
A visitor checks in at a pop-up monkeypox vaccination site in West Hollywood, Calif.
Richard Vogel/AP